Stocktoria
Zomedica Corp. ZOMDF
OTC · stock · Pharmaceutical Preparations · website · IPO 2013-10-28
Zomedica Corp. statistics & valuation
Market cap$88.1M
P / S2.8×
P / B0.8×
Net margin-255.6%
Return on equity-70.9%
FCF margin-56.9%
Return on capital-71.7%
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 67.7% | 70.0% | 68.8% | 71.1% | 73.9% | — | — | — | — | — |
| Operating margin | -263.4% | -187.1% | -171.8% | -115.8% | -517.1% | — | — | — | — | — |
| Net margin | -255.6% | -172.2% | -137.1% | -89.9% | -444.8% | — | — | — | — | — |
| FCF margin | -56.9% | -105.7% | -108.4% | -65.8% | -349.0% | — | — | — | — | — |
| Return on assets | -64.4% | -22.7% | -13.6% | -6.1% | -6.6% | -25.6% | -473.0% | -275.9% | -154.6% | -125.5% |
| Return on equity | -70.9% | -24.0% | -14.4% | -6.4% | -6.8% | -33.1% | -944.1% | -455.2% | -183.8% | -149.7% |
| Debt / equity | — | — | — | — | — | 0.01× | — | — | — | — |
| Current ratio | 6.78 | 8.76 | 11.06 | 15.81 | 46.18 | 31.48 | 0.87 | 1.62 | 5.14 | 4.83 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.